Financhill
Back

MediPharm Labs Quote, Financials, Valuation and Earnings

MediPharm Labs Price Quote

$0.05

MediPharm Labs Key Stats

Sell
23
MediPharm Labs (MEDIF) is a Sell

Day range:
$0.05 - $0.05
52-week range:
$0.04 - $0.07
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.75
P/B ratio:
0.59%

Volume:
13.8K
Avg. volume:
138.6K
1-year change:
5.38%
Market cap:
$20.5M
Revenue:
$24.5M
EPS:
$-0.03

How Much Does MediPharm Labs Make?

Is MediPharm Labs Growing As A Company?

  • What Is MediPharm Labs's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.06%
  • What Is MediPharm Labs's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

MediPharm Labs Stock Price Performance

  • Did MediPharm Labs Stock Go Up Last Month?
    MediPharm Labs share price went down by -8.35% last month
  • Did MEDIF's Share Price Rise Over The Last Year?
    MEDIF share price rose by 5.38% over the past 1 year

What Is MediPharm Labs 52-Week High & Low?

MediPharm Labs Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy MediPharm Labs?

  • How Much Debt Does MediPharm Labs Have?
    Total long term debt quarterly is $2M
  • How Much Cash Does MediPharm Labs Have?
    Cash and short term investments quarterly total is $11.7M
  • What Is MediPharm Labs’s Book Value Per Share?
    Book value per share is 0.08

Is MediPharm Labs Cash Flow Positive?

  • What Is MEDIF Cash Flow From Operations?
    Cash flow from operations (TTM) is -$3.6M
  • What Is MediPharm Labs’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $51.9K
  • What Is MediPharm Labs’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $4.8M

MediPharm Labs Return On Invested Capital

  • Is Management Doing A Good Job?
    MEDIF return on invested capital is -24.23%
  • What Is MediPharm Labs Return On Assets?
    ROA measures how assets are converting to revenues and is -20.53%
  • What Is MEDIF Return On Equity?
    ROE is a measure of profitability and is -25.33%

MediPharm Labs Earnings Date & Stock Price

MediPharm Labs Competitors

  • Who Are MediPharm Labs's Competitors?
    Below is a list of companies who compete with MediPharm Labs or are related in some way:
    • Aurinia Pharmaceuticals Inc (AUPH)
    • Edesa Biotech Inc (EDSA)
    • ESSA Pharma Inc (EPIX)
    • Lexaria Bioscience Corp (LEXX)
    • Xenon Pharmaceuticals Inc (XENE)

MediPharm Labs Dividend Yield

MediPharm Labs Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 6.15% -15.17%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

  • How many MEDIF shares are owned by institutional investors?
    2.9M MEDIF shares are owned by institutional investors
  • How many MEDIF shares are owned by insiders?
    0 MEDIF shares are owned by insiders